Search alternatives:
teer decrease » greater decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
15341
Data_Sheet_1_A Phenome-Wide Association Study of the Effects of Fusarium graminearum Transcription Factors on Fusarium Graminearum Virus 1 Infection.pdf
Published 2021“…The FgV1-infected TF deletion mutants in Group 1 exhibited slow or weak mycelial growth compare to that of WT-VI on complete medium at 5 dpi. …”
-
15342
Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation
Published 2016“…While MYC was required for MCT1 induction, MCPyV-induced MCT1 levels decreased following knockdown of the NF-κB subunit RelA, supporting a synergistic activity between MCPyV and MYC in regulating MCT1 levels. …”
-
15343
-
15344
-
15345
-
15346
-
15347
-
15348
A Family of Binuclear Dysprosium(III) Radical Compounds with Magnetic Relaxation in ON and OFF States
Published 2012“…The adduct ([Dy(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub>[Dy<sub>0.5</sub>(hfac)<sub>1.5</sub>(H<sub>2</sub>O)]<sub>2</sub>) (<b>3</b>) consists of two items, the dimer [Dy(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub> and the monomer [Dy(hfac)<sub>3</sub>(H<sub>2</sub>O)<sub>2</sub>], where the symmetry of Dy<sup>III</sup> ion in Dy<sub>2</sub>O<sub>2</sub> decreases to <i>D</i><sub>2<i>d</i></sub>, showing slow relaxation of the magnetization at lower temperature. …”
-
15349
-
15350
-
15351
-
15352
-
15353
-
15354
The data of meta-analysis.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
15355
Quality assessment for risk of bias for studies.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
15356
Effect of tirzepatide vs placebo on body weight.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
15357
The results of safety in meta-analysis.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
15358
Graphs of risk of bias for studies.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
15359
General baseline of included studies.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
15360